herbal Unani treatment for getting pregnant

Effect of Habbe Hamal and Majoon Suparipak in Anovulatory infertility: A Clinical Study. - HH_MS in infertility

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086145

Enrollment

Registered

2025-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Habbe Hamal and Majoon Suparipak: Habb e hamal 1 tab twice daily orally with milk from the D8 of menstrual cycle for 3 days along with this Majoon SupariPak 7 gm twice daily orally. C

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 18-40 years. Anxious to conceive for more than 1year Features of polycystic ovarian disease. No follicular growth and ovulation on imaging. Serum progesterone less than 10ng/mL Both primary and secondary infertility Spouse with normal seminogram.

Exclusion criteria

Exclusion criteria: Diagnosed cases of primary ovarian failure, malignancy. Women on hormonal therapy for anovulation within last 3 months. Women with DM, Hypertension, Thyroid dysfunction, hyperprolactinaemia

Design outcomes

Primary

Measure	Time frame
OvulationTimepoint: 1st month, 2nd month 3rd month during treatment, and once after treatment	—

Secondary

Measure	Time frame
ConceptionTimepoint: 5 weeks	—

Countries

India

Contacts

Public ContactDr KOUSER FATHIMA FIRDOSE

National Institute of unani medicine

kouser2fathima@gmail.com09141762284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026